Skip to main content
Earnings Labs
Nektar Therapeutics logo

Nektar Therapeutics (NKTR)

NASDAQ·Healthcare·Biotechnology

$36.70

-1.50%

Mkt Cap $1.06B

Analyst Ratings

Buy

6

Hold

1

Sell

0

Price Target (19 analysts)

$146.00

Range $50.00 – $192.00

Implied Upside

+297.8%

Consensus $146.00 vs current $36.70